| [1] |
Reaven GM. Banting lecture 1988. Role of insulin resistance in human disease[J]. Diabetes, 1988, 37(12):1595-1607.
|
| [2] |
Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation[J]. Diabet Med, 1998, 15(7):539-553.
|
| [3] |
Balkau B, Charles MA. Comment on the provisional report from the WHO consultation. European Group for the Study of Insulin Resistance (EGIR)[J]. Diabet Med, 1999, 16(5):442-443.
|
| [4] |
Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP). Expert panel on detection, evaluation, and treatment of high blood cholesterol in adults：adult treatment panel Ⅲ[J]. JAMA, 2001, 285(19):2486-2497.
|
| [5] |
Alberti KG, Zimmet P, Shaw J. The metabolic syndrome: a new worldwide definition[J]. Lancet, 2005, 366(9491):1059-1062.
|
| [6] |
Gu DF, Reynolds K, Yang WJ, et al. The prevalence of metabolic syndrome in the general adult population aged 35274 years in China[J]. Chin J Diabetes, 2005, 13(3):181-186.
|
| [7] |
Sacks GP, Studena K, Sargent K, et al. Normal pregnancy and preeclampsia both produce inflammatory changes in peripheral blood leukocytes akin to those of sepsis[J]. Am J Obstet Gynecol, 1998, 179(1):80-86.
|
| [8] |
Sattar N, Greer IA. Pregnancy complications and maternal cardiovascular risk: opportunities for intervention and screening？[J]. BMJ, 2002, 325(7356):157-160.
|
| [9] |
Niu JM, Lei Q, Lv LJ, et al. Evaluation of the diagnostic criteria of gestational metabolic syndrome and analysis of the risk factors[J]. Chin J Obstet Gynecol, 2013, 48(2):92-97.
|
| [10] |
Bautista-Castano I, Henriquez-Sanchez P, Aleman-Perez N, et al. Maternal obesity in early pregnancy and risk of adverse outcomes[J]. PLoS One, 2013, 8(11):e804-e810.
|
| [11] |
Chatzi L, Plana E, Pappas A, et al. The metabolic syndrome in early pregnancy and risk of gestational diabetes mellitus[J]. Diabetes Metab, 2009, 35(6):490-494.
|
| [12] |
Mosca L, Benjamin EJ, Berra K, et al. Effectiveness-based guidelines for the prevention of cardiovascular disease in women——2011 update：a guideline from the american heart association[J]. Circulation, 2011, 123(11):1243-1262.
|
| [13] |
Rodbard HW, Green AJ, Fox KM, et al. Trends in method of diagnosis of type 2 diabetes mellitus: results from SHIELD[J]. Int J Endocrinol, 2009, 796206.[2013-11-22].
URL
|
| [14] |
Lambrinoudaki I, Vlachou SA, Creatsas G. Genetics in gestational diabetes mellitus: association with incidence, severity, pregnancy outcome and response to treatment[J]. Curr Diabetes Rev, 2010, 6(6):393-399.
|
| [15] |
Edalat B, Sharifi F, Badamchizadeh Z, et al. Association of metabolic syndrome with inflammatory mediators in women with previous gestational diabetes mellitus[J]. J Diabetes Metab Disord, 2013, 12(1):8-11.
|
| [16] |
Lopez-Tinoco C, Roca M, Fernandez-Deudero A, et al. Cytokine profile, metabolic syndrome and cardiovascular disease risk in women with late-onset gestational diabetes mellitus[J]. Cytokine, 2012, 58(1):14-19.
|
| [17] |
Akinci B, Celtik A, Yener S, et al. Prediction of developing metabolic syndrome after gestational diabetes mellitus[J]. Fertil Steril, 2010, 93(4):1248-1254.
|
| [18] |
Srinivas SK, Sammel MD, Bastek J, et al. Evaluating the association between all components of the metabolic syndrome and pre-eclampsia[J]. J Matern Fetal Neonatal Med, 2009, 22(6):501-509.
|
| [19] |
Ray JG, Vermeulen MJ, Schull MJ, et al. Metabolic syndrome and the risk of placental dysfunction[J]. J Obstet Gynaecol Can, 2005, 27(12):1095-1101.
|
| [20] |
Brown MC, Best KE, Pearce MS, et al. Cardiovascular disease risk in women with pre-eclampsia: systematic review and meta-analysis[J]. Eur J Epidemiol, 2013, 28(1):1-19.
|
| [21] |
Van Rijn BB, Nijdam ME, Bruinse HW, et al. Cardiovascular disease risk factors in women with a history of early-onset preeclampsia[J]. Obstet Gynecol, 2013, 121(5):1040-1048.
|
| [22] |
Stekkinger E, Zandstra M, Peeters LL, et al. Early-onset preeclampsia and the prevalence of postpartum metabolic syndrome[J]. Obstet Gynecol, 2009, 114(5):1076-1084.
|
| [23] |
Spaan JJ, Sep SJ, van Balen VL, et al. Metabolic syndrome as a risk factor for hypertension after preeclampsia[J]. Obstet Gynecol, 2012, 120(2 Pt 1):311-317.
|
| [24] |
Barker DJ. The fetal and infant origins of disease[J]. Eur J Clin Invest, 1995, 25(7):457-463.
|
| [25] |
Mori M, Mori H, Yamori Y, et al. Low birth weight as cardiometabolic risk in Japanese high school girls[J]. J Am Coll Nutr, 2012, 31(1):39-44.
|
| [26] |
Tian JY, Cheng Q, Song XM, et al. Birth weight and risk of type 2 diabetes, abdominal obesity and hypertension among Chinese adults[J]. Eur J Endocrinol, 2006, 155(4):601-607.
|
| [27] |
Norris SA, Osmond C, Gigante D, et al. Size at birth, weight gain in infancy and childhood, and adult diabetes risk in five low- or middle-income country birth cohorts[J]. Diabetes Care, 2012, 35(1):72-79.
|
| [28] |
Guerrero-Romero F, Aradillas-Garcia C, Simental-Mendia LE, et al. Birth weight, family history of diabetes, and metabolic syndrome in children and adolescents[J]. J Pediatr, 2010, 156(5):719-723.
|
| [29] |
Boney CM, Verma A, Tucker R, et al. Metabolic syndrome in childhood: association with birth weight, maternal obesity, and gestational diabetes mellitus[J]. Pediatrics, 2005, 115(3):e290-e296.
|